Concepedia

Publication | Open Access

Frequency of CYP2D6 Alleles Including Structural Variants in the United States

124

Citations

21

References

2018

Year

TLDR

CYP2D6 encodes an enzyme critical for metabolizing many common medications, and genetic variation in this gene leads to inter‑individual differences in drug response, prompting the use of genetic testing to tailor therapy. The authors conducted a retrospective analysis of CYP2D6 allele frequencies in 104,509 de‑identified patient samples from across the United States. They identified 37 distinct CYP2D6 alleles, including structural variants that were present in 13.1 % of individuals (representing 7 % of all variants) and accounted for roughly 30 % of poor metabolizers, with 73 % of these variants being decreased‑ or no‑function alleles, underscoring the substantial impact of structural variants on CYP2D6 function.

Abstract

The CYP2D6 gene encodes an enzyme important in the metabolism of many commonly used medications. Variation in CYP2D6 is associated with inter-individual differences in medication response, and genetic testing is used to optimize medication therapy. This report describes a retrospective study of CYP2D6 allele frequencies in a large population of 104,509 de-identified patient samples across all regions of the United States (US). Thirty-seven unique CYP2D6 alleles including structural variants were identified. A majority of these alleles had frequencies which matched published frequency data from smaller studies, while eight had no previously published frequencies. Importantly, CYP2D6 structural variants were observed in 13.1% of individuals and accounted for 7% of the total variants observed. The majority of structural variants detected (73%) were decreased-function or no-function alleles. As such, structural variants were found in approximately one-third (30%) of CYP2D6 poor metabolizers in this study. This is the first CYP2D6 study to evaluate, with a consistent methodology, both structural variants and single copy alleles in a large US population, and the results suggest that structural variants have a substantial impact on CYP2D6 function.

References

YearCitations

Page 1